glp-1 pill news today The FDA approved a new from Eli Lilly on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication New GLP-1 Pill Foundayo (Orforglipron)

Suppresses appetite by acting on the brains hunger centers

In contrast, pharmacologically decreasing the biosynthesis of glutathione leads to increases in cytosolic glutamate and enhanced mEPSC frequency

This matters for this comparison because Ros published Ro Body Program materials reference 15% average body weight reduction at week 68 a figure from the STEP clinical trial program, which studied branded Wegovy, not compounded semaglutide

Of the total body weight lost with tirzepatide, around three quarters was fat mass and about a quarter was lean mass, a split that was almost identical to the placebo group, who lost a similar amount of weight through diet and lifestyle changes alone rather than medication